Novel nano-pomegranates based on astragalus polysaccharides for targeting ERα-positive breast cancer and multidrug resistance
Bingjie Wang, Chunjing Guo, Yan‐Hui Liu, Guangting Han, Yi Li, Yanchun Zhang, Haiyu Xu, Daquan Chen
Abstract
antitumor experiments showed that nano-pomegranates have better anti-tumor effects and lower systemic toxicity than free Cur. In conclusion, nano-pomegranates have great potential in anti-breast cancer treatment.
Topics & Concepts
NanocarriersMultiple drug resistanceBreast cancerPharmacologyBreast cancer chemotherapyCancer cellChemistryCancerCancer researchMedicineDrugBiochemistryInternal medicineAntibioticsPomegranate: compositions and health benefitsBiological Activity of Diterpenoids and BiflavonoidsTannin, Tannase and Anticancer Activities